ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Arogo Capital Acquisition Corporation

Arogo Capital Acquisition Corporation (AOGO)

10.96
0.00
(0.00%)
Closed January 13 3:00PM
10.96
0.00
( 0.00% )
Pre Market: 6:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
10.96
Bid
10.95
Ask
11.14
Volume
-
0.00 Day's Range 0.00
10.75 52 Week Range 11.6406
Market Cap
Previous Close
10.96
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
1,762,409
Dividend Yield
-
PE Ratio
15.19
Earnings Per Share (EPS)
0.83
Revenue
-
Net Profit
1.46M

About Arogo Capital Acquisition Corporation

Arogo Capital Acquisition Corp is a blank check company. Arogo Capital Acquisition Corp is a blank check company.

Sector
Prepackaged Software
Industry
Prepackaged Software
Headquarters
Wilmington, Delaware, USA
Founded
-
Arogo Capital Acquisition Corporation is listed in the Prepackaged Software sector of the NASDAQ with ticker AOGO. The last closing price for Arogo Capital Acquisition was US$10.96. Over the last year, Arogo Capital Acquisition shares have traded in a share price range of US$ 10.75 to US$ 11.6406.

Arogo Capital Acquisition currently has 1,762,409 shares outstanding. The market capitalization of Arogo Capital Acquisition is US$19.32 million. Arogo Capital Acquisition has a price to earnings ratio (PE ratio) of 15.19.

AOGO Latest News

Arogo Capital Acquisition Corp. Announces Binding Letter of Intent with Bangkok Tellink Co., Ltd, a Provider of Innovative Telecommunications and IoT Solutions, in Connection with a Proposed Business Combination Transaction

MIAMI, Fla. and BANGKOK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Arogo Capital Acquisition Corp. (“Arogo Capital”) (OTC: AOGO) today announced that it has signed a binding letter of intent (“LOI”...

Arogo Capital Acquisition Corp. Announces Receipt of Nasdaq Delisting Notice

MIAMI BEACH, FL, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Arogo Capital Acquisition Corp. (“Arogo” or the “Company”) (Nasdaq: AOGO/AOGOU/AOGOW), a special purpose acquisition company, today announced...

Arogo Capital Acquisition Corp. Announces Receipt of and Appeals Nasdaq Delisting Determination

MIAMI BEACH, FL, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Arogo Capital Acquisition Corp. (“Arogo” or the “Company”) (Nasdaq: AOGO/AOGOU/AOGOW), a special purpose acquisition company, today announced...

Arogo Capital Acquisition Corp. Announces Termination of Merger Agreement with EON Reality, Inc.

MIAMI BEACH, FL, Nov. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Arogo Capital Acquisition Corp. (“Arogo” or the “Company”) (Nasdaq: AOGO/AOGOU/AOGOW), a special purpose acquisition...

Arogo Capital Acquisition Corp. Announces Stockholder Approval of Extension of Deadline to Complete Business Combination

NEW YORK, NY, Sept. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire  — On September 28, 2023, Arogo Capital Acquisition Corp. (the “Company” or “Arogo”) (Nasdaq: AOGO/AOGOU/AOGOW), a special...

Arogo Capital Acquisition Corp. Announces Stockholder Approval of Extension of Deadline to Complete Business Combination

NEW YORK, NY, March 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – On March 28, 2023, Arogo Capital Acquisition Corp. (the “Company” or “Arogo”) (Nasdaq: AOGO/AOGOU/AOGOW), a special purpose...

Arogo Capital Acquisition Corp. Announces Pricing of $90,000,000 Initial Public Offering

Miami, FL, Dec. 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Arogo Capital Acquisition Corp. (the “Company”) announced today that it priced its initial public offering of 9,000,000 units at...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10010.9610.9610.9600CS
40010.9610.9610.9600CS
120010.9610.9610.9600CS
260.010.091324200913310.9511.020110.91164710.98301872CS
520.121.1070110701110.8411.640610.75607810.87350674CS
1561.1611.83673469399.811.66939.81950510.2627571CS
2601.1611.83673469399.811.66939.81950510.2627571CS

AOGO - Frequently Asked Questions (FAQ)

What is the current Arogo Capital Acquisition share price?
The current share price of Arogo Capital Acquisition is US$ 10.96
How many Arogo Capital Acquisition shares are in issue?
Arogo Capital Acquisition has 1,762,409 shares in issue
What is the market cap of Arogo Capital Acquisition?
The market capitalisation of Arogo Capital Acquisition is USD 19.32M
What is the 1 year trading range for Arogo Capital Acquisition share price?
Arogo Capital Acquisition has traded in the range of US$ 10.75 to US$ 11.6406 during the past year
What is the PE ratio of Arogo Capital Acquisition?
The price to earnings ratio of Arogo Capital Acquisition is 15.19
What is the reporting currency for Arogo Capital Acquisition?
Arogo Capital Acquisition reports financial results in USD
What is the latest annual profit for Arogo Capital Acquisition?
The latest annual profit of Arogo Capital Acquisition is USD 1.46M
What is the registered address of Arogo Capital Acquisition?
The registered address for Arogo Capital Acquisition is CORPORATION TRUST CENTER, 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Arogo Capital Acquisition website address?
The website address for Arogo Capital Acquisition is www.arogocapital.com
Which industry sector does Arogo Capital Acquisition operate in?
Arogo Capital Acquisition operates in the PREPACKAGED SOFTWARE sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
STAFStaffing 360 Solutions Inc
US$ 3.89
(70.99%)
1.62M
PIIIP3 Partners Inc
US$ 0.3203
(49.05%)
4.22M
DMNDamon Inc
US$ 0.8971
(30.79%)
431.66k
SNESSenesTech Inc
US$ 3.79
(27.61%)
1
GXAIGaxos ai Inc
US$ 2.10
(25.75%)
673.84k
RIMEAlgorhythm Holdings Inc
US$ 0.0768
(-23.58%)
1.43M
PHIOPhio Pharmaceuticals Corporation
US$ 5.09
(-22.88%)
193.78k
SVMHSRIVARU Holding Ltd
US$ 0.0271
(-22.79%)
2.72M
CTRNCiti Trends Inc
US$ 20.51
(-21.99%)
1
SMXSMX Security Matters Public Company
US$ 0.2041
(-21.50%)
273.31k
PIIIP3 Partners Inc
US$ 0.3203
(49.05%)
4.22M
GCTKGlucoTrack Inc
US$ 0.1316
(-12.09%)
3.68M
LAESSEALSQ Corporation
US$ 3.825
(14.18%)
3.35M
SVMHSRIVARU Holding Ltd
US$ 0.0271
(-22.79%)
2.72M
SHViShares Short Treasury Bond ETF
US$ 110.26
(0.01%)
2.38M

Discussion

View Full Feed
Number sleven Number sleven 3 minutes ago
https://www.courtlistener.com/docket/59859757/dr-reddys-laboratories-inc-v-amarin-pharma-inc/?page=2
Sleven,
AMRN
price_and_volume price_and_volume 7 minutes ago
"Right news" gonna get $175-350MM market cap? LOL!

Omg what a maroon.
VXIT
The Danish Dude The Danish Dude 7 minutes ago
Nice and interesting analysis, but completely irrelevant >!

I fed ChatGPT the following five comments regarding this analysis and it disagrees with you.

I saw these comments regarding how MHRA approves or rejects medecines at mhra meetings

1
NWBO
lakers17 lakers17 9 minutes ago
MTC back to $96,000 after hitting $89, 200s yesterday. Cryptos I added to in the last couple of days were BOBO, PAI, OTTO and CLUSTR. RING AI looking better. Boom or bust for me.
MTC
Golden Cross Golden Cross 12 minutes ago
Loading Zone Here! $ASII
ASII
Hi_Lo Hi_Lo 20 minutes ago
Where is the CSE press release filing?

TWOH has been halted for more than a week now and the CSE press release is still missing.

Could the run up before the halt be the problem?

Could some people have been tipped off before the run up?

Coul
TWOH
SkeBallLarry SkeBallLarry 28 minutes ago
https://scontent-mia3-1.xx.fbcdn.net/v/t39.30808-6/473323273_992397186268896_4170433101098362110_n.jpg?_nc_cat=100&ccb=1-7&_nc_sid=833d8c&_nc_ohc=UebR9WKXEXsQ7kNvgELlMGV&_nc_zt=23&_nc_ht=scontent-mia3-1.xx&_nc_gid=AvB9U-Cb1bfWGguzkXzMzar&oh=00_AYDqG-tA0ScuUz90hSjz11X1LQL5aezyuhOfdBXmp9pGuQ&oe=678C04
Dodger1 Dodger1 30 minutes ago
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175652942 I Miss Real
AABB
jondoeuk jondoeuk 33 minutes ago
NEUK201-00* is being tested in advanced/metastatic solid tumours at a single site.

https://i.postimg.cc/fyWcxcwj/download.png

* It could be an iNK with just a high-affinity non-cleavable CD16(a) receptor, but this comes from a Chinese site that has under
HPQ
marcis marcis 34 minutes ago
I was just thinking the same thing

Go bother those serial OTC stock hijackers
( we know them all well ) that’s been doing LOI mergers, asset ( no asset ) transfers for years with never a real company.
( not you Prophet, to the shills )
Save those investors
RDAR
No-Quarter No-Quarter 35 minutes ago
Good to know, thx!
LetGoodTimesRoll LetGoodTimesRoll 35 minutes ago
The criminality surrounding BLUE Sheets data is rampant...

https://www.sec.gov/newsroom/press-releases/2025-5?utm_medium=email&utm_source=govdelivery
FOXO
Seminole Red Seminole Red 36 minutes ago
https://scontent-mia3-2.xx.fbcdn.net/v/t39.30808-6/472742874_1004087688423643_1614366062036311373_n.jpg?_nc_cat=1&ccb=1-7&_nc_sid=833d8c&_nc_ohc=nfcGrMsEIhAQ7kNvgF3nw1U&_nc_zt=23&_nc_ht=scontent-mia3-2.xx&_nc_gid=AZgGdnGS_3zIT8EnJ2PY5KX&oh=00_AYA_PYWQyRmy2OxdvryhKxL8uHQSf69FZtEDZ_CZJ06VFQ&oe=678BF3D
Bubae Bubae 36 minutes ago
New shares flying everywhere from the looks of the filings. Form 144 filed on January 10th by Atlas Merchant Capital LLC intent to sell 1,241,144 shares. approximate date of sale listed as 01/10/2025. Robert E. Diamond, Triller Chairman of the Board, Chief Executive Officer of Atlas Merchant Capita
ILLR
meshcan meshcan 38 minutes ago
Yes, hence I was saying the really numbers will be in a couple quarters from now, August CC will be two full quarters that we have Vyvanse sell numbers.

CC: NASDAC2020
ELTP
PlaneReflection PlaneReflection 38 minutes ago
Remember when you said it won't pass $2 again?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174119656

Please say it won't pass $10 again, $30 again and it'll never be over $200. Thanks.
FNMA
eagle8 eagle8 40 minutes ago
ATLnsider
@ATLnsider
Global future for $NWBO #DCVax dendritic cell vaccine platform could be unlimited if efficacy is proven to be tumor & tissue agnostic for all solid tumor cancers & when combined with checkpoint inhibitors can also effectively treat all blood or liquid cancers. NWBi
NWBO
PROPHET-of-PROFITS PROPHET-of-PROFITS 40 minutes ago
The old CEO of rdar has a new stock already to transfer all of his garbage into. But you watch the bearish comments here Will Never follow Jacob to that new stock where efforts should be made to protect people from making a bad investment. Negative bearish comments and all the effort to create them
RDAR
Pickme2 Pickme2 41 minutes ago
The only proof here is you constantly saying this is the best setup and challenge...yet it keeps going down down from .31 cents to .03 ...now .05  and despite the company saying this S-1 offering filled with the SEC will cause dilution and shareholders will have a hard time selling...you continue to
ATMH
PC retired PC retired 43 minutes ago
Yes, it has gone deathly quiet. I have little to say other than wishing you, Richard H2, a happy and prosperous new year.
ASRE
eagle8 eagle8 44 minutes ago
Someone without a name wrote this ;)

➡️MTD Timeline: More Speculation⬅️

For all of those, including myself, (im)patiently waiting for $NWBO's spoofing case Motion to Dismiss (MTD) decision, I've done a deep dive into Magistrate Judge Stein's Report and Recommendation (R
NWBO
marcis marcis 47 minutes ago
Agree
The deep experience management team is on this
And with $45 million working capital

Buckle up
RDAR
marcis marcis 51 minutes ago
It’s my opinion that, JanBelle Capital or an associate fund, was the short buyer of $100k one big size trade at the high of the day .002 Dec 06

I think that the short position, if I’m correct, is about finished after making a cool $80,00” - $90,000 minus fees for the month
RDAR

Your Recent History

Delayed Upgrade Clock